A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Myeloid Neoplasm Mutation Analysis Only : 1016478
Test CodeMDFCPMYLSEQ or 1016478
CPT Codes
81450
Includes
Includes: ASXL1, CALR, CBL, CEBPA, CSF3R, DNMT3A, ETV6, EZH2, FLT3, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NPM1, NRAS, PHF6, PTEN, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, U2AF1, WT1
Instructions
Peripheral Blood in a lavender top (EDTA) tube and/or a green top sodium heparin tube.
OR
Bone Marrow in a lavender top (EDTA) tube and/or a green top sodium heparin tube.
OR
Bone Marrow in a lavender top (EDTA) tube and/or a green top sodium heparin tube.
Transport Container
Peripheral Blood in a lavender top (EDTA) tube and/or a green top sodium heparin tube.
OR
Bone Marrow in a lavender top (EDTA) tube and/or a green top sodium heparin tube.
OR
Bone Marrow in a lavender top (EDTA) tube and/or a green top sodium heparin tube.
Transport Temperature
Refrigerated.
Specimen Stability
Ambient: 48 hours; Refrigerated: 15 days; Frozen: Unacceptable
Methodology
Next Generation Sequencing, PCR and Fragment Analysis, and for CEBPA only Next Generation Sequencing at Quest Diagnostics San Juan Capistrano Laboratory
Setup Schedule
Monday & Wednesday & Friday
Report Available
10-14 days
Reference Range
Mutation not detected.
Clinical Significance
The Myeloid Neoplasm Mutation Only panel aids in the diagnosis, prognosis and treatment of patients with unspecified myeloid lineage neoplasms, chronic myelomonocytic leukemia (CMML), or myelodysplastic/myeloproliferative (MDS/MPN) neoplasm overlap sydromes.
Performing Laboratory
med fusion; CEBPA Quest SJC